News

Dr. Georgia Tomaras Elected Fellow in American Academy of Microbiology

Georgia Tomaras, PhD, Professor in Surgery, Division of Surgical Sciences, has been elected to Fellowship in the American Academy of Microbiology. Dr. Tomaras was one of 96 new fellows chosen worldwide through a highly selective peer-review process. Fellows of the American Academy of Microbiology represent all subspecialties of the microbial sciences, and are elected based on their record of originality, leadership, and contributions to the field of microbiology.

Duke Surgery Faculty Selected for 2018 Duke LEADER Program

Five faculty members from the Duke Department of Surgery have been selected to participate in the 2018 Duke Leadership Development for Researchers (LEADER) program sponsored by the Duke University School of Medicine Office of Faculty Development.

Duke Surgery’s participants include the following members:

Duke-Led Team Develops More Accurate Tool to Track New HIV Infections

Population-based model would benefit research and public health initiatives worldwide
 

Researchers at the Duke Human Vaccine Institute have led an effort to develop a more accurate way to gauge the incidence of HIV infections in large populations, which will improve research and prevention strategies worldwide.

Abstract Presented at AACR Conference on the Science of Cancer Health Disparities in Minorities and the Medically Underserved

 

An abstract resulting from the joint collaboration between Surgical Sciences faculty member Gayathri Devi, PhD, and Kevin Williams, PhD, North Carolina Central University, was recently presented by Helen Oladapo, PhD, at the 10th Annual American Association for Cancer Research (AACR) Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved.

Poliovirus Therapy Induces Immune Responses Against Cancer

Investigational therapy directly kills tumor cells and unmasks them to the body’s defenses

An investigational therapy using modified poliovirus to attack cancer tumors appears to unleash the body’s own capacity to fight malignancies by activating an inflammation process that counter’s the ability of cancer cells to evade the immune system.